Cargando…

The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma

PURPOSE: Increased awareness of the distinct tumor biology for adolescents and young adults (AYAs) with cancer has led to improvement in outcomes for this population. However, in cholangiocarcinoma (CCA), a paucity of data exist on the AYA population. To our knowledge, we present the largest study t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pappas, Leontios, Baiev, Islam, Reyes, Stephanie, Bocobo, Andrea Grace, Jain, Apurva, Spencer, Kristen, Le, Tri Minh, Rahma, Osama E., Maurer, Jordan, Stanton, Jen, Zhang, Karen, De Armas, Anaemy Danner, Deleon, Thomas T., Roth, Marc, Peters, Mary Linton B., Zhu, Andrew X., Boyhen, Kylie, VanCott, Christine, Patel, Tushar, Roberts, Lewis R., Lindsey, Stacie, Horick, Nora, Lennerz, Jochen K., Iafrate, A. John, Goff, Laura Williams, Mody, Kabir, Borad, Mitesh J., Shroff, Rachna T., Javle, Milind M., Kelley, R. Katie, Goyal, Lipika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581631/
https://www.ncbi.nlm.nih.gov/pubmed/37561981
http://dx.doi.org/10.1200/PO.22.00594
_version_ 1785122177765343232
author Pappas, Leontios
Baiev, Islam
Reyes, Stephanie
Bocobo, Andrea Grace
Jain, Apurva
Spencer, Kristen
Le, Tri Minh
Rahma, Osama E.
Maurer, Jordan
Stanton, Jen
Zhang, Karen
De Armas, Anaemy Danner
Deleon, Thomas T.
Roth, Marc
Peters, Mary Linton B.
Zhu, Andrew X.
Boyhen, Kylie
VanCott, Christine
Patel, Tushar
Roberts, Lewis R.
Lindsey, Stacie
Horick, Nora
Lennerz, Jochen K.
Iafrate, A. John
Goff, Laura Williams
Mody, Kabir
Borad, Mitesh J.
Shroff, Rachna T.
Javle, Milind M.
Kelley, R. Katie
Goyal, Lipika
author_facet Pappas, Leontios
Baiev, Islam
Reyes, Stephanie
Bocobo, Andrea Grace
Jain, Apurva
Spencer, Kristen
Le, Tri Minh
Rahma, Osama E.
Maurer, Jordan
Stanton, Jen
Zhang, Karen
De Armas, Anaemy Danner
Deleon, Thomas T.
Roth, Marc
Peters, Mary Linton B.
Zhu, Andrew X.
Boyhen, Kylie
VanCott, Christine
Patel, Tushar
Roberts, Lewis R.
Lindsey, Stacie
Horick, Nora
Lennerz, Jochen K.
Iafrate, A. John
Goff, Laura Williams
Mody, Kabir
Borad, Mitesh J.
Shroff, Rachna T.
Javle, Milind M.
Kelley, R. Katie
Goyal, Lipika
author_sort Pappas, Leontios
collection PubMed
description PURPOSE: Increased awareness of the distinct tumor biology for adolescents and young adults (AYAs) with cancer has led to improvement in outcomes for this population. However, in cholangiocarcinoma (CCA), a paucity of data exist on the AYA population. To our knowledge, we present the largest study to date on AYA disease biology, treatment patterns, and survival outcomes in CCA. METHODS: A multi-institutional cohort of patients with CCA diagnosed with intrahepatic cholangiocarcinoma (ICC) or extrahepatic cholangiocarcinoma (ECC) was used for analysis. Retrospective chart review was conducted on patients who were 50 years old and younger (young; n = 124) and older than 50 years (older; n = 723). RESULTS: Among 1,039 patients screened, 847 patients met eligibility (72% ICC, 28% ECC). Young patients had a larger median tumor size at resection compared with older patients (4.2 v 3.6 cm; P = .048), more commonly had N1 disease (65% v 43%; P = .040), and were more likely to receive adjuvant therapy (odds ratio, 4.0; 95% CI, 1.64 to 9.74). Tumors of young patients were more likely to harbor an FGFR2 fusion, BRAF mutation, or ATM mutation (P < .05 for each). Young patients were more likely to receive palliative systemic therapy (96% v 69%; P < .001), targeted therapy (23% v 8%; P < .001), and treatment on a clinical trial (31% v 19%; P = .004). Among patients who presented with advanced disease, young patients had a higher median overall survival compared with their older counterparts (17.7 v 13.5 months; 95% CI, 12.6 to 22.6 v 11.4 to 14.8; P = .049). CONCLUSION: Young patients with CCA had more advanced disease at resection, more commonly received both adjuvant and palliative therapies, and demonstrated improved survival compared with older patients. Given the low clinical trial enrollment and poor outcomes among some AYA cancer populations, data to the contrary in CCA are highly encouraging.
format Online
Article
Text
id pubmed-10581631
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-105816312023-10-18 The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma Pappas, Leontios Baiev, Islam Reyes, Stephanie Bocobo, Andrea Grace Jain, Apurva Spencer, Kristen Le, Tri Minh Rahma, Osama E. Maurer, Jordan Stanton, Jen Zhang, Karen De Armas, Anaemy Danner Deleon, Thomas T. Roth, Marc Peters, Mary Linton B. Zhu, Andrew X. Boyhen, Kylie VanCott, Christine Patel, Tushar Roberts, Lewis R. Lindsey, Stacie Horick, Nora Lennerz, Jochen K. Iafrate, A. John Goff, Laura Williams Mody, Kabir Borad, Mitesh J. Shroff, Rachna T. Javle, Milind M. Kelley, R. Katie Goyal, Lipika JCO Precis Oncol ORIGINAL REPORTS PURPOSE: Increased awareness of the distinct tumor biology for adolescents and young adults (AYAs) with cancer has led to improvement in outcomes for this population. However, in cholangiocarcinoma (CCA), a paucity of data exist on the AYA population. To our knowledge, we present the largest study to date on AYA disease biology, treatment patterns, and survival outcomes in CCA. METHODS: A multi-institutional cohort of patients with CCA diagnosed with intrahepatic cholangiocarcinoma (ICC) or extrahepatic cholangiocarcinoma (ECC) was used for analysis. Retrospective chart review was conducted on patients who were 50 years old and younger (young; n = 124) and older than 50 years (older; n = 723). RESULTS: Among 1,039 patients screened, 847 patients met eligibility (72% ICC, 28% ECC). Young patients had a larger median tumor size at resection compared with older patients (4.2 v 3.6 cm; P = .048), more commonly had N1 disease (65% v 43%; P = .040), and were more likely to receive adjuvant therapy (odds ratio, 4.0; 95% CI, 1.64 to 9.74). Tumors of young patients were more likely to harbor an FGFR2 fusion, BRAF mutation, or ATM mutation (P < .05 for each). Young patients were more likely to receive palliative systemic therapy (96% v 69%; P < .001), targeted therapy (23% v 8%; P < .001), and treatment on a clinical trial (31% v 19%; P = .004). Among patients who presented with advanced disease, young patients had a higher median overall survival compared with their older counterparts (17.7 v 13.5 months; 95% CI, 12.6 to 22.6 v 11.4 to 14.8; P = .049). CONCLUSION: Young patients with CCA had more advanced disease at resection, more commonly received both adjuvant and palliative therapies, and demonstrated improved survival compared with older patients. Given the low clinical trial enrollment and poor outcomes among some AYA cancer populations, data to the contrary in CCA are highly encouraging. Wolters Kluwer Health 2023-08-10 /pmc/articles/PMC10581631/ /pubmed/37561981 http://dx.doi.org/10.1200/PO.22.00594 Text en © 2023 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle ORIGINAL REPORTS
Pappas, Leontios
Baiev, Islam
Reyes, Stephanie
Bocobo, Andrea Grace
Jain, Apurva
Spencer, Kristen
Le, Tri Minh
Rahma, Osama E.
Maurer, Jordan
Stanton, Jen
Zhang, Karen
De Armas, Anaemy Danner
Deleon, Thomas T.
Roth, Marc
Peters, Mary Linton B.
Zhu, Andrew X.
Boyhen, Kylie
VanCott, Christine
Patel, Tushar
Roberts, Lewis R.
Lindsey, Stacie
Horick, Nora
Lennerz, Jochen K.
Iafrate, A. John
Goff, Laura Williams
Mody, Kabir
Borad, Mitesh J.
Shroff, Rachna T.
Javle, Milind M.
Kelley, R. Katie
Goyal, Lipika
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma
title The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma
title_full The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma
title_fullStr The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma
title_full_unstemmed The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma
title_short The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma
title_sort cholangiocarcinoma in the young (city) study: tumor biology, treatment patterns, and survival outcomes in adolescent young adults with cholangiocarcinoma
topic ORIGINAL REPORTS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581631/
https://www.ncbi.nlm.nih.gov/pubmed/37561981
http://dx.doi.org/10.1200/PO.22.00594
work_keys_str_mv AT pappasleontios thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT baievislam thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT reyesstephanie thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT bocoboandreagrace thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT jainapurva thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT spencerkristen thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT letriminh thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT rahmaosamae thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT maurerjordan thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT stantonjen thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT zhangkaren thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT dearmasanaemydanner thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT deleonthomast thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT rothmarc thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT petersmarylintonb thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT zhuandrewx thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT boyhenkylie thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT vancottchristine thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT pateltushar thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT robertslewisr thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT lindseystacie thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT horicknora thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT lennerzjochenk thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT iafrateajohn thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT gofflaurawilliams thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT modykabir thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT boradmiteshj thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT shroffrachnat thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT javlemilindm thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT kelleyrkatie thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT goyallipika thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT pappasleontios cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT baievislam cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT reyesstephanie cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT bocoboandreagrace cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT jainapurva cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT spencerkristen cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT letriminh cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT rahmaosamae cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT maurerjordan cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT stantonjen cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT zhangkaren cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT dearmasanaemydanner cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT deleonthomast cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT rothmarc cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT petersmarylintonb cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT zhuandrewx cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT boyhenkylie cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT vancottchristine cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT pateltushar cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT robertslewisr cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT lindseystacie cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT horicknora cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT lennerzjochenk cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT iafrateajohn cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT gofflaurawilliams cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT modykabir cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT boradmiteshj cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT shroffrachnat cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT javlemilindm cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT kelleyrkatie cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma
AT goyallipika cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma